High-Flow Nasal Cannula Utilization in Pediatric Critical Care

Area of Science:

• Pediatric critical care medicine
• Respiratory therapy

Background:

• High-flow nasal cannula (HFNC) is increasingly used in pediatric intensive care units (PICUs) for respiratory support.
• Evidence suggests better tolerance and lower complications in neonates, but data on pediatric indications and epidemiology are limited.

Purpose of the Study:

• To describe the indications, patient demographics, and utilization patterns of HFNC in a pediatric ICU.
• To analyze the diseases and pathologies leading to HFNC use in critically ill children.

Main Methods:

• Retrospective cohort study of patients admitted to a PICU from October 2011 to October 2013.
• Descriptive statistics were used to analyze demographics and HFNC utilization.
• T-tests were employed for comparative analyses.

Main Results:

• HFNC was used in 620 subjects (27% of PICU admissions), with a mean age of 3.74 years.
• Primary indications included status asthmaticus (24%), pneumonia with status asthmaticus (17%), and bronchiolitis (16%).
• Rhinovirus/enterovirus was the most common respiratory viral infection (53.8%), associated with higher peak flow requirements.

Conclusions:

• HFNC is a common respiratory support modality in pediatric ICUs for diverse conditions.
• Standardized protocols for HFNC initiation, escalation, and weaning are needed to optimize its utilization.